People & Places

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 16 No 7
Volume 16
Issue 7

Dr. Sarah Donaldson, Dr. Robert Kyle, Dr. Scott Lippman

Dr. Sarah Donaldson

ASCO presented the 2007 Pediatric Oncology Award to Sarah S. Donaldson, MD, professor of radiation oncology at Stanford Comprehensive Cancer Center in California. Dr. Donaldson was recognized for her work in increasing the understanding of and the cure rates for various childhood cancers. She also serves as associate chair of radiation oncology at Stanford University School of Medicine.

Dr. Robert Kyle

Robert A. Kyle, MD, professor of medicine and laboratory medicine at the Mayo Medical School, Rochester, Minnesota, was awarded the David A. Karnofsky Memorial Award at ASCO 2007 for his extensive research in hematology. He is director of the Scientific Advisory Board for the International Myeloma Foundation and chairman of ECOG's Myeloma Committee.

Dr. Scott Lippman

The American Cancer Society Award was given to Scott M. Lippman, MD, at ASCO 2007 in recognition of his work in cancer prevention. Dr. Lippman chairs the Department of Clinical Cancer Prevention at M.D. Anderson Cancer Center and is professor of both clinical cancer prevention and thoracic/head and neck medical oncology. His research interests are focused on translational chemoprevention studies.

Related Videos
Cretostimogene grenadenorepvec’s efficacy compares favorably with the current nonsurgical standards of care in high-risk, Bacillus Calmette Guerin–unresponsive non-muscle invasive bladder cancer.
Artificial intelligence models may be “seamlessly incorporated” into clinical workflow in the management of prostate cancer, says Eric Li, MD.
Panelists smiling at camera on a blue background.
Panelists smiling at camera on a blue background.
Robust genetic testing guidelines in the prostate cancer space must be supported by strong clinical research before they can be properly implemented, says William J. Catalona, MD.
Treatment with tisotumab vedotin may be a standard of care in second- or third-line recurrent or metastatic cervical cancer, says Brian Slomovitz, MD, MS, FACOG.
A panel of 4 experts on multiple myeloma seated at a long table
A panel of 4 experts on multiple myeloma seated at a long table
Teresa Macarulla, MD, PhD, and Cindy Neuzillet, MD, PhD, experts on NRG1 fusion-positive malignancies
Teresa Macarulla, MD, PhD, and Cindy Neuzillet, MD, PhD, experts on NRG1 fusion-positive malignancies
Related Content